publication venue for
- BAY 81-8973 Demonstrates Long-Term Safety and Efficacy in Children With Severe Haemophilia A: Results From the LEOPOLD Kids Extension Study.. 114:556-565. 2025
- Treatment of Critical Bleeds in Patients With Immune Thrombocytopenia: A Systematic Review.. 114:458-468. 2025
- Outcome of carfilzomib/pomalidomide‐based regimens after daratumumab‐based treatment in relapsed multiple myeloma: A Canadian Myeloma Research Group Database analysis. 111:815-823. 2023
-
Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A—Final efficacy and safety results from the
NuProtect study. 111:544-552. 2023 -
Patient age and donor
HLA matching can stratify allogeneic hematopoietic cell transplantation patients into prognostic groups. 109:672-679. 2022 - Tyrosine kinase inhibitors and tumor lysis syndrome in hematologic malignancies: A systemic review. 109:166-181. 2022
-
Important questions for the malignant hematologist to consider when designing or evaluating a study with patient‐reported outcome measures (
PROMs ). 109:3-9. 2022 - Poor outcome after hematopoietic stem cell transplantation of patients with unclassified inherited bone marrow failure syndromes. 108:278-287. 2022
- Utilization of a surgical database to provide care and assess perioperative treatment and outcomes in patients with bleeding disorders. 108:232-243. 2022
- T cell–mediated autoimmunity in immune thrombocytopenia. 108:18-27. 2022
- Comorbidities and complications in adults with pyruvate kinase deficiency. 106:484-492. 2021
- Maintenance therapy in transplant ineligible adults with newly‐diagnosed multiple myeloma: A systematic review and meta‐analysis. 105:626-634. 2020
- How we treat paroxysmal nocturnal hemoglobinuria: A consensus statement of the Canadian PNH Network and review of the national registry. 102:36-52. 2019
- Quantifying immature platelets as markers of increased platelet production after coronary artery bypass grafting surgery. 101:362-367. 2018
- Screening and diagnostic clinical algorithm for paroxysmal nocturnal hemoglobinuria: Expert consensus. 101:3-11. 2018
- Bacterial neuraminidase‐mediated erythrocyte desialylation provokes cell surface aminophospholipid exposure. 100:502-510. 2018
- Clinical evaluation of a hemochromatosis next‐generation sequencing gene panel. 98:228-234. 2017
-
Gender and
BCR ‐ABL transcript type are correlated with molecular response to imatinib treatment in patients with chronic myeloid leukemia. 96:360-366. 2016 - Haemophilia in a real‐world setting: the value of clinical experience in data collection. 96:3-9. 2016
- Antibody binding to megakaryocytes in vivo in patients with immune thrombocytopenia. 95:532-537. 2015
-
Gigantic splenomegaly in a 27‐year‐old male of
S outh‐E astA sian descent with concurrent diagnosis of myeloproliferative neoplasm and hemoglobinH disease. 91:284-285. 2013 - A blinded study of bone marrow examinations in patients with primary immune thrombocytopenia. 90:121-126. 2013
- Extended thromboprophylaxis: defining the case, refining the approach. 85:4-11. 2010
- Meeting the Unmet Needs in Anticoagulant Therapy. 85:1-28. 2010
- Perioperative management of MYH9 hereditary macrothrombocytopenia (Fechtner syndrome). 79:263-268. 2007
- Sickle cell disease due to compound heterozygosity for Hb S and a novel 7.7‐kb β‐globin gene deletion. 78:82-85. 2007
- Is there convincing evidence for the use of chemotherapy alone in patients with limited stage Hodgkin's lymphoma?. 75:115-120. 2005
- Recurrent palmar–plantar erythrodysaesthesia following high‐dose cytarabine treatment for acute lymphoblastic leukemia. 69:315-317. 2002
- Rearrangement of TCR gamma chain gene involving JP1 suggests early thymocyte origin of peripheral T‐cell lymphoma. 42:368-374. 1989
- HIV‐serology and lymphocyte subsets in relation to therapy and clinical development in haemophiliacs. 41:459-466. 1988
- Modulation of human erythropoiesis by hydrocortisone in vitro. 38:137-140. 1987
- Factors and inhibitors of blood coagulation and fibrinolysis in acute nonlymphoblastic leukaemia. 34:332-339. 1985
- North American Study of Factor VIII Concentrate Potency. 33:149-160. 1984
- The Effects of Cisplatin on Normal Human Erythrocytes in Vitro. 31:283-286. 1983
- An Apparent Lack of HLA Restriction in the Stimulation of Granulocyte‐Macrophage Colony Formation from Normal Human Null Cells by Helper T Lymphocytes. 31:23-30. 1983
- Hydrocortisone — A Possible Physiological Regulator of Human Granulopoiesis. 31:31-38. 1983
- Acetylesterase in Lymphoblastic Leukaemia Associated with Thymic Enlargement. 30:420-426. 1983
- Vinblastine‐Induced Erythrocytotoxicity. 28:32-38. 1982
- Erythrocytotoxicity Induced by Cancer Chemotherapeutic Agents. 25:363-368. 1981
- Preleukaemia and Reticulocytosis: A Case Report with in Vitro Evidence for Abnormal Reticulocyte Maturation. 20:417-422. 1978
- Diagnosis of Intravascular Haemolysis Using Starch Gel Electrophoresis. 19:343-346. 1977
- Pseudothrombocytopenia Due to Platelet Aggregation and Degranulation in Blood Collected in EDTA. 15:161-170. 1975